{"DataElement":{"publicId":"7118713","version":"1","preferredName":"Metastatic Diagnosis Hepatocellular Carcinoma Risk Factor History Category","preferredDefinition":"An individual's attribute, characteristic or exposure that increases the likelihood of developing a disease that arises from hepatocytes resulting in hepatocellular carcinoma, or as diffuse liver involvement.","longName":"7115532v1.0:7114213v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7115532","version":"1","preferredName":"Metastatic Diagnosis Risk Factor History","preferredDefinition":"Any diagnosis indicating the presence of metastatic disease._A record of an individual's attribute, characteristic or exposure that increases the likelihood of developing a disease or injury. (WHO)","longName":"6841515v1.0:7115530v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"6841515","version":"1","preferredName":"Metastatic Diagnosis","preferredDefinition":"Any diagnosis indicating the presence of metastatic disease.","longName":"C162221","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic Diagnosis","conceptCode":"C162221","definition":"Any diagnosis indicating the presence of metastatic disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EFAFAB2-E712-5A45-E053-F662850A0775","latestVersionIndicator":"Yes","beginDate":"2019-07-31","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-07-31","modifiedBy":"ONEDATA","dateModified":"2019-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7115530","version":"1","preferredName":"Risk Factor History","preferredDefinition":"A record of an individual's attribute, characteristic or exposure that increases the likelihood of developing a disease or injury. (WHO)","longName":"C157153","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Risk Factor History","conceptCode":"C157153","definition":"A record of an individual's attribute, characteristic or exposure that increases the likelihood of developing a disease or injury. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AB73A5A-E3CE-6CE2-E053-F662850AF2CB","latestVersionIndicator":"Yes","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9AB73A5A-E3DF-6CE2-E053-F662850AF2CB","latestVersionIndicator":"Yes","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"KNABLEJ","dateModified":"2020-06-14","changeDescription":"6/14/20 jk added CPTAC ESCA Baseline CSI. 2/14/20 jk Released per CPTAC SME (Linda) review and approval. 12/27/19 jk created for CPTAC LIHC baseline CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7114213","version":"1","preferredName":"Hepatocellular Carcinoma Risk Factor History Category","preferredDefinition":"A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. Lately, an increasing number of tumors have been treated with liver transplantation._A record of an individual's attribute, characteristic or exposure that increases the likelihood of developing a disease or injury. (WHO)_A grouping of items based on some commonality or by user defined characteristics.","longName":"7114213v1.0","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unknown: Could not be determined or unsure.","valueDescription":"Indeterminate or Unknown","ValueMeaning":{"publicId":"6841632","version":"1","preferredName":"Indeterminate or Unknown","longName":"6841632","preferredDefinition":"An indication that something is indeterminate or unknown.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate or Unknown","conceptCode":"C157157","definition":"An indication that something is indeterminate or unknown.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EFB6B26-0C86-5A31-E053-F662850A5C7D","latestVersionIndicator":"Yes","beginDate":"2019-07-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-31","modifiedBy":"ONEDATA","dateModified":"2019-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AB1232A-EC37-704D-E053-F662850A3107","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","deletedIndicator":"No"},{"value":"Alpha 1-Antitrypsin Disease","valueDescription":"Alpha-1 Antitrypsin Deficiency","ValueMeaning":{"publicId":"3171840","version":"1","preferredName":"Alpha-1 Antitrypsin Deficiency","longName":"3171840","preferredDefinition":"A genetic disorder characterized by decreased alpha-1 antitrypsin activity in the lungs and blood and deposition of alpha-1 antitrypsin protein in the hepatocytes. These abnormalities result from defective production of alpha-1 antitrypsin and lead to the development of emphysema, cirrhosis, and liver failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alpha-1 Antitrypsin Deficiency","conceptCode":"C84397","definition":"A genetic disorder characterized by decreased alpha-1 antitrypsin activity in the lungs and blood and deposition of alpha-1 antitrypsin protein in the hepatocytes. These abnormalities result from defective production of alpha-1 antitrypsin and lead to the development of emphysema, cirrhosis, and liver failure.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97DDA7EA-0146-07E7-E040-BB89AD4351C6","latestVersionIndicator":"Yes","beginDate":"2010-12-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AB1232A-EC4B-704D-E053-F662850A3107","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","deletedIndicator":"No"},{"value":"Non-Alcoholic Fatty Liver Disease","valueDescription":"Nonalcoholic Fatty Liver Disease","ValueMeaning":{"publicId":"3171842","version":"1","preferredName":"Nonalcoholic Fatty Liver Disease","longName":"3171842","preferredDefinition":"A term referring to fatty replacement of the hepatic parenchyma which is not related to alcohol use.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nonalcoholic Fatty Liver Disease","conceptCode":"C84444","definition":"A term referring to fatty replacement of the hepatic parenchyma which is not related to alcohol use.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97DDA7EA-016C-07E7-E040-BB89AD4351C6","latestVersionIndicator":"Yes","beginDate":"2010-12-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AB1232A-EC56-704D-E053-F662850A3107","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","deletedIndicator":"No"},{"value":"Hemochromatosis","valueDescription":"Hemochromatosis","ValueMeaning":{"publicId":"3171844","version":"1","preferredName":"Hemochromatosis","longName":"3171844","preferredDefinition":"An inherited metabolic disorder characterized by iron accumulation in the tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hereditary Hemochromatosis","conceptCode":"C84481","definition":"An inherited metabolic disorder characterized by iron accumulation in the tissues.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97DDA7EA-0192-07E7-E040-BB89AD4351C6","latestVersionIndicator":"Yes","beginDate":"2010-12-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AB1232A-EC61-704D-E053-F662850A3107","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","deletedIndicator":"No"},{"value":"Hepatitis C","valueDescription":"Hepatitis C","ValueMeaning":{"publicId":"2975596","version":"1","preferredName":"Hepatitis C","longName":"2975596","preferredDefinition":"An RNA virus, causes non-A and non-B Hepatitis and liver cancer","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis C Infection","conceptCode":"C3098","definition":"A viral infection caused by the hepatitis C virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C084539-0F01-6AD0-E040-BB89AD43189B","latestVersionIndicator":"Yes","beginDate":"2009-12-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AB1232A-EC6C-704D-E053-F662850A3107","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","deletedIndicator":"No"},{"value":"Hepatitis B","valueDescription":"Hepatitis B Infection","ValueMeaning":{"publicId":"4761116","version":"1","preferredName":"Hepatitis B Infection","longName":"4761116v1.00","preferredDefinition":"A viral infection caused by the hepatitis B virus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis B Infection","conceptCode":"C3097","definition":"A viral infection caused by the hepatitis B virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"12375748-2AE9-8D8D-E050-BB89AD430CF5","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"MAESKEB","dateCreated":"2015-03-26","modifiedBy":"GDEEN","dateModified":"2023-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AB1232A-EC77-704D-E053-F662850A3107","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","deletedIndicator":"No"},{"value":"Alcohol Consumption","valueDescription":"Alcohol Consumption","ValueMeaning":{"publicId":"5025993","version":"1","preferredName":"Alcohol Consumption","longName":"5025993","preferredDefinition":"consumption of liquids containing ethanol; includes the behavior of drinking the alcohol.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alcohol Consumption","conceptCode":"C16273","definition":"Consumption of liquids containing ethanol, including the behaviors associated with drinking the alcohol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"20D29B95-82D4-6C89-E050-BB89AD437D47","latestVersionIndicator":"Yes","beginDate":"2015-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-09-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AB1232A-EC8C-704D-E053-F662850A3107","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","deletedIndicator":"No"},{"value":"None","valueDescription":"Risk Factor History Negative","ValueMeaning":{"publicId":"7114215","version":"1","preferredName":"Risk Factor History Negative","longName":"7114215","preferredDefinition":"The determination that an individual's risk factor history is negative.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Risk Factor History Negative","conceptCode":"C159672","definition":"The determination that an individual's risk factor history is negative.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AB1232A-EC9A-704D-E053-F662850A3107","latestVersionIndicator":"Yes","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AB1232A-ECB3-704D-E053-F662850A3107","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"5697874","version":"1","preferredName":"Other","longName":"5697874","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A253837-4DE2-5542-E053-F662850A338C","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-03-07","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AB1232A-ECBD-704D-E053-F662850A3107","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008526","version":"1","preferredName":"Anatomic Sites","preferredDefinition":"locations or structures in the human body.","longName":"ANAT_SITES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ED0F8B-4D91-332D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7114212","version":"1","preferredName":"Hepatocellular Carcinoma Risk Factor History Category","preferredDefinition":"A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. The overall median survival of untreated liver cell carcinoma is about 4 months. The most effective treatment of hepatocellular carcinoma is complete resection of the tumor. Lately, an increasing number of tumors have been treated with liver transplantation.:A record of an individual's attribute, characteristic or exposure that increases the likelihood of developing a disease or injury. (WHO):A grouping of items based on some commonality or by user defined characteristics.","longName":"C3099:C157153:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatocellular Carcinoma","conceptCode":"C3099","definition":"A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. The overall median survival of untreated liver cell carcinoma is about 4 months. The most effective treatment of hepatocellular carcinoma is complete resection of the tumor. Lately, an increasing number of tumors have been treated with liver transplantation.","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"2"},{"longName":"Risk Factor History","conceptCode":"C157153","definition":"A record of an individual's attribute, characteristic or exposure that increases the likelihood of developing a disease or injury. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AB1232A-EC0E-704D-E053-F662850A3107","latestVersionIndicator":"Yes","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9AB1232A-EC1F-704D-E053-F662850A3107","latestVersionIndicator":"Yes","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"KNABLEJ","dateModified":"2020-02-14","changeDescription":"2/14/20 jk Released per CPTAC SME (Linda) review and approval.  12/27/19 jk created for CPTAC LIHC baseline CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"6776762","version":"1","longName":"Bile duct and Liver","context":"OCCPR"},{"publicId":"6779541","version":"1","longName":"LIHC Baseline","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"History of Risk Factors","type":"Preferred Question Text","description":"History of Risk Factors","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9B058F86-4DF9-1FC7-E053-F662850AE8F9","latestVersionIndicator":"Yes","beginDate":"2019-12-31","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-31","modifiedBy":"KNABLEJ","dateModified":"2020-02-17","changeDescription":"2/14/20 jk Released per CPTAC SME (Linda) review and approval. 12/31/19 jk created for CPTAC LIHC baseline CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}